Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma

Increasing evidence has demonstrated that Ctr1 plays a crucial role in the regulation of cisplatin uptake in a variety of tumors. The purpose of this study was to investigate its role in mediating cisplatin sensitivity in ESCC cells. Immunohistochemistry (IHC), In situ hybridization (ISH) and semi-q...

Full description

Bibliographic Details
Main Authors: Xin Wang, Qianqian Lou, Tianli Fan, Qing Zhang, Xiangxiang Yang, Hongtao Liu, Ruitai Fan
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Translational Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323000116
_version_ 1797936419082076160
author Xin Wang
Qianqian Lou
Tianli Fan
Qing Zhang
Xiangxiang Yang
Hongtao Liu
Ruitai Fan
author_facet Xin Wang
Qianqian Lou
Tianli Fan
Qing Zhang
Xiangxiang Yang
Hongtao Liu
Ruitai Fan
author_sort Xin Wang
collection DOAJ
description Increasing evidence has demonstrated that Ctr1 plays a crucial role in the regulation of cisplatin uptake in a variety of tumors. The purpose of this study was to investigate its role in mediating cisplatin sensitivity in ESCC cells. Immunohistochemistry (IHC), In situ hybridization (ISH) and semi-quantitative RT-PCR were used to detect Ctr1 expressions in ESCC tissues. qRT-PCR and Western blot was performed to investigate the levels of Ctr1 mRNA and protein in ESCC cells. CCK-8, Flow cytometry and Transwell chamber assay were carried out to examine cell proliferation, apoptosis, migration and invasion abilities in ESCC cells. We found that ESCC tissues and cells had higher Ctr1 level than normal tissues and Het-1A cell. Ctr1 expression was correlated with histological grade, invasion depth, TNM staging and lymph node metastasis in ESCC patients. Ctr1 depletion reduced the suppressive role of proliferation, migration and invasion as well as the inductive role of cell apoptosis and Caspase-3 activity evoked by cisplatin, whereas Ctr1 upregulation combined with cisplatin exerted the synergistic role in regulation of proliferation, apoptosis, Caspase-3 activity, migration and invasion in ESCC. In conclusion, Ctr1 is implicated in ESCC development and progression and its expression may be a novel predictor for assessment of cisplatin sensitivity in ESCC.
first_indexed 2024-04-10T18:30:30Z
format Article
id doaj.art-fabf70e474f24b8ca50d67af5c66a524
institution Directory Open Access Journal
issn 1936-5233
language English
last_indexed 2024-04-10T18:30:30Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Translational Oncology
spelling doaj.art-fabf70e474f24b8ca50d67af5c66a5242023-02-02T04:48:11ZengElsevierTranslational Oncology1936-52332023-03-0129101626Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinomaXin Wang0Qianqian Lou1Tianli Fan2Qing Zhang3Xiangxiang Yang4Hongtao Liu5Ruitai Fan6Department of Radiotherapy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaSchool of Life Sciences, Zhengzhou University, Zhengzhou, Henan, 450001, ChinaDepartment of Pharmacology, School of Basic Medicine, Zhengzhou University, 100 Kexue Road, Zhengzhou, Henan, 450001, ChinaTranslational Medicine Research Center, Zhengzhou People's Hospital, Zhengzhou, Henan, 450003, ChinaDepartment of Radiotherapy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, ChinaSchool of Life Sciences, Zhengzhou University, Zhengzhou, Henan, 450001, China; Translational Medicine Research Center, Zhengzhou People's Hospital, Zhengzhou, Henan, 450003, China; Corresponding author at: College of Life Sciences, Zhengzhou University, 100 Kexue Road, Zhengzhou, 450001, China.Department of Radiotherapy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China; Corresponding author at: Department of Radiotherapy, the First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou, Henan, 450052, China.Increasing evidence has demonstrated that Ctr1 plays a crucial role in the regulation of cisplatin uptake in a variety of tumors. The purpose of this study was to investigate its role in mediating cisplatin sensitivity in ESCC cells. Immunohistochemistry (IHC), In situ hybridization (ISH) and semi-quantitative RT-PCR were used to detect Ctr1 expressions in ESCC tissues. qRT-PCR and Western blot was performed to investigate the levels of Ctr1 mRNA and protein in ESCC cells. CCK-8, Flow cytometry and Transwell chamber assay were carried out to examine cell proliferation, apoptosis, migration and invasion abilities in ESCC cells. We found that ESCC tissues and cells had higher Ctr1 level than normal tissues and Het-1A cell. Ctr1 expression was correlated with histological grade, invasion depth, TNM staging and lymph node metastasis in ESCC patients. Ctr1 depletion reduced the suppressive role of proliferation, migration and invasion as well as the inductive role of cell apoptosis and Caspase-3 activity evoked by cisplatin, whereas Ctr1 upregulation combined with cisplatin exerted the synergistic role in regulation of proliferation, apoptosis, Caspase-3 activity, migration and invasion in ESCC. In conclusion, Ctr1 is implicated in ESCC development and progression and its expression may be a novel predictor for assessment of cisplatin sensitivity in ESCC.http://www.sciencedirect.com/science/article/pii/S1936523323000116Esophageal squamous cell carcinomaCopper transporter 1CisplatinAntitumor efficacy
spellingShingle Xin Wang
Qianqian Lou
Tianli Fan
Qing Zhang
Xiangxiang Yang
Hongtao Liu
Ruitai Fan
Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
Translational Oncology
Esophageal squamous cell carcinoma
Copper transporter 1
Cisplatin
Antitumor efficacy
title Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
title_full Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
title_fullStr Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
title_full_unstemmed Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
title_short Copper transporter Ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
title_sort copper transporter ctr1 contributes to enhancement of the sensitivity of cisplatin in esophageal squamous cell carcinoma
topic Esophageal squamous cell carcinoma
Copper transporter 1
Cisplatin
Antitumor efficacy
url http://www.sciencedirect.com/science/article/pii/S1936523323000116
work_keys_str_mv AT xinwang coppertransporterctr1contributestoenhancementofthesensitivityofcisplatininesophagealsquamouscellcarcinoma
AT qianqianlou coppertransporterctr1contributestoenhancementofthesensitivityofcisplatininesophagealsquamouscellcarcinoma
AT tianlifan coppertransporterctr1contributestoenhancementofthesensitivityofcisplatininesophagealsquamouscellcarcinoma
AT qingzhang coppertransporterctr1contributestoenhancementofthesensitivityofcisplatininesophagealsquamouscellcarcinoma
AT xiangxiangyang coppertransporterctr1contributestoenhancementofthesensitivityofcisplatininesophagealsquamouscellcarcinoma
AT hongtaoliu coppertransporterctr1contributestoenhancementofthesensitivityofcisplatininesophagealsquamouscellcarcinoma
AT ruitaifan coppertransporterctr1contributestoenhancementofthesensitivityofcisplatininesophagealsquamouscellcarcinoma